Author | Narendranath Epperla, MBBS, MS | OncLive

Author | Narendranath Epperla, MBBS, MS

Articles

Dr. Epperla on FDA Approval of Frontline Obinutuzumab in Follicular Lymphoma

November 16, 2017

Video

Narendranath Epperla, MBBS, MS, hematologist, Department of Internal Medicine, Division of Hematology, Ohio State University Comprehensive Cancer Center, discusses the FDA approval of frontline obinutuzumab (Gazyva) for the treatment of patients with follicular lymphoma.

Dr. Epperla on CAR T-Cell Therapy in MCL

November 15, 2017

Video

Narendranath Epperla, MBBS, MS, hematologist, The Ohio State University (OSU) Comprehensive Cancer Center, assistant professor in internal medicine, OSU, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with mantle cell lymphoma (MCL).

Dr. Epperla on Treatment Following Ibrutinib in MCL

November 01, 2017

Video

Narendranath Epperla, MBBS, MS, hematologist, The Ohio State University (OSU) Comprehensive Cancer Center, assistant professor in internal medicine, OSU, discusses the next steps for patients with mantle cell lymphoma (MCL) who fail ibrutinib (Imbruvica).

Dr. Epperla Discusses the Current Treatment of MCL

October 18, 2017

Video

Narendranath Epperla, MBBS, MS, hematologist, The Ohio State University Comprehensive Cancer Center, assistant professor in internal medicine, OSU, discusses the current treatment landscape of patients with mantle cell lymphoma.

x